Obstetric and neonatal outcomes for women with reversed and non-reversed type III female genital mutilation

SA Raouf, T Ball, A Hughes, Roger Holder, S Papaioannou

    Research output: Contribution to journalArticle

    14 Citations (Scopus)

    Abstract

    Objective: To record and compare obstetric and neonatal complication rates in women with reversed and non-reversed type III female genital mutilation (FGM). Methods: A retrospective observational study comparing cesarean delivery rates and neonatal outcomes of primiparous and multiparous women who had or had not undergone reversal of FGM III. Results: Of the 250 women, 230 (92%) had an FGM reversal. Of these, 50(21.7%) were primiparous (cesarean delivery rate 17/50; 34%) and 180 (78.3%) were multiparous (cesarean delivery rate 28/180; 15.6%). Of the 20 women who had not had an FGM reversal, 7 (35%) were primiparous (cesarean delivery rate 5/7; 71.4%) and 13 (65%) were multiparous (cesarean delivery rate 7/13; 53.8%). The cesarean delivery rates for primiparae and multiparae were 32.9% and 25%, respectively. Multiparous women with FGM III reversal had a lower possibility of cesarean delivery compared with the hospital multiparous population (P=0.003) and multiparae who had not undergone FGM III reversal (P=0.007). There was no significant association between Apgar scores or blood loss at vaginal delivery and FGM reversal. Conclusion: Reversal of FGM III significantly reduced the increased risk of cesarean delivery seen with multiparae who have FGM III. (C) 2011 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
    Original languageEnglish
    Pages (from-to)141-143
    Number of pages3
    JournalInternational Journal of Gynecology & Obstetrics
    Volume113
    Issue number2
    DOIs
    Publication statusPublished - 1 May 2011

    Keywords

    • Reversal of female genital mutilation
    • Infibulation
    • Female genital mutilation
    • Defibulation

    Fingerprint

    Dive into the research topics of 'Obstetric and neonatal outcomes for women with reversed and non-reversed type III female genital mutilation'. Together they form a unique fingerprint.

    Cite this